Phase I Trial of Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis

被引：0
|
作者：
Chan, Carlos H. [1 ]
Lu, Ze [2 ]
Wientjes, Guill [2 ]
Au, Jessie [2 ]
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[2] Inst Quantitat Syst Pharmacol, Carlsbad, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A49
引用
收藏
页码：527 / 527
页数：1
相关论文
共 50 条
  • [1] Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology
    Badgwell, Brian
    Blum, Mariela
    Ikoma, Naruhiko
    Estrella, Jeannelyn
    Li, Jenny
    Kawedia, Jitesh
    Mansfield, Paul F.
    Ajani, Jaffer
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S36 - S36
  • [2] Phase I trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and peritoneal carcinomatosis or positive peritoneal cytology.
    Badgwell, Brian D.
    Blum-Murphy, Mariela A.
    Ikoma, Naruhiko
    Estrella, Jeannelyn
    Li, Jenny Jing
    Kawedia, Jitesh D.
    Mansfield, Paul F.
    Ajani, Jaffer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 360 - 360
  • [3] Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial
    Murono, Koji
    Nagata, Hiroshi
    Ishimaru, Kazuhiro
    Emoto, Shigenobu
    Kaneko, Manabu
    Hiyoshi, Masaya
    Sasaki, Kazuhito
    Otani, Kensuke
    Shuno, Yasutaka
    Nishikawa, Takeshi
    Tanaka, Toshiaki
    Hata, Keisuke
    Kawai, Kazushige
    Nozawa, Hiroaki
    Muro, Kei
    Ishihara, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (01) : 145 - 150
  • [4] Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial
    Koji Murono
    Hiroshi Nagata
    Kazuhiro Ishimaru
    Shigenobu Emoto
    Manabu Kaneko
    Masaya Hiyoshi
    Kazuhito Sasaki
    Kensuke Otani
    Yasutaka Shuno
    Takeshi Nishikawa
    Toshiaki Tanaka
    Keisuke Hata
    Kazushige Kawai
    Hiroaki Nozawa
    Kei Muro
    Soichiro Ishihara
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 145 - 150
  • [5] Novel intraperitoneal treatment for peritoneal metastases: results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I clinical trial
    Flatmark, Kjersti
    Andersson, Yvonne
    Davidson, Ben
    Dueland, Svein
    Fodstad, Oystein
    Froysnes, Ida S.
    Giercksky, Karl Erik
    Julsrud, Lars
    Larsen, Stein G.
    Olsen, Kari H.
    Oien, Janne M. T.
    CANCER RESEARCH, 2016, 76
  • [6] Phase I clinical trial of cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy for the treatment of peritoneal carcinomatosis
    Li, Y.
    Yang, X.
    Yang, G.
    Zhang, J.
    Chen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy
    Simon-Gracia, Lorena
    Hunt, Hedi
    Scodeller, Pablo D.
    Gaitzsch, Jens
    Braun, Gary B.
    Willmore, Anne-Mari A.
    Ruoslahti, Erkki
    Battaglia, Giuseppe
    Teesalu, Tambet
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (04) : 670 - 679
  • [8] Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
    Maheswari Senthil
    Farshid Dayyani
    BMC Cancer, 23
  • [9] Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis-STOPGAP trial
    Senthil, Maheswari
    Dayyani, Farshid
    BMC CANCER, 2023, 23 (01)
  • [10] A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
    Cristea, Mihaela C.
    Frankel, Paul
    Synold, Timothy
    Rivkin, Saul
    Lim, Dean
    Chung, Vincent
    Chao, Joseph
    Wakabayashi, Mark
    Paz, Benjamin
    Han, Ernest
    Lin, Paul
    Leong, Lucille
    Hakim, Amy
    Carroll, Mary
    Prakash, Neal
    Dellinger, Thanh
    Park, Min
    Morgan, Robert J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 589 - 598
12345